Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-27

FDA Approved: ENTYVIO — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

ENTYVIO (vedolizumab) received FDA approval under the original application by Takeda Pharmaceuticals America for the treatment of adult patients with moderate t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entyvio (vedolizumab)

Snippet

ORIG AP for ENTYVIO (VEDOLIZUMAB)